Royal Bank of Canada
IONS icon

Royal Bank of Canada’s Ionis Pharmaceuticals IONS Stock Holding History

Royal Bank of Canada’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,500
Closed -$1.94M – 7393
2025
Q4 		$1.94M Sell
24,500
-66,700
-73% -$5.02M ﹤0.01% 3164
2025
Q3 		$5.97M Buy
+91,200
New +$4.45M ﹤0.01% 2527
2025
Q1 		– Sell
-40,000
Closed -$1.4M – 7023
2024
Q4 		$1.4M Sell
40,000
-22,700
-36% -$848K ﹤0.01% 3288
2024
Q3 		$2.51M Sell
62,700
-111,600
-64% -$5.19M ﹤0.01% 2818
2024
Q2 		$8.31M Buy
174,300
+149,300
+597% +$6.12M ﹤0.01% 1801
2024
Q1 		$1.08M Buy
25,000
+24,500
+4,900% +$1.17M ﹤0.01% 3394
2023
Q4 		$25K Hold
500
– – ﹤0.01% 6243
2023
Q3 		$23K Buy
+500
New +$20.6K ﹤0.01% 6129
2020
Q1 		– Sell
-45,000
Closed -$2.72M – 6834
2019
Q4 		$2.72M Hold
45,000
– – ﹤0.01% 2617
2019
Q3 		$2.7M Hold
45,000
– – ﹤0.01% 2517
2019
Q2 		$2.89M Hold
45,000
– – ﹤0.01% 2482
2019
Q1 		$3.65M Sell
45,000
-4,100
-8% -$264K ﹤0.01% 2242
2018
Q4 		$2.65M Hold
49,100
– – ﹤0.01% 2439
2018
Q3 		$2.53M Hold
49,100
– – ﹤0.01% 2663
2018
Q2 		$2.05M Hold
49,100
– – ﹤0.01% 2711
2018
Q1 		$2.16M Hold
49,100
– – ﹤0.01% 2635
2017
Q4 		$2.47M Buy
49,100
+3,600
+8% +$197K ﹤0.01% 2559
2017
Q3 		$2.31M Buy
+45,500
New +$2.38M ﹤0.01% 2553
2016
Q1 		– Sell
-258,500
Closed -$16M – 6499
2015
Q4 		$16M Buy
258,500
+145,400
+129% +$7.85M 0.01% 1113
2015
Q3 		$4.57M Buy
113,100
+112,100
+11,210% +$5.8M ﹤0.01% 1634
2015
Q2 		$58K Hold
1,000
– – ﹤0.01% 5149
2015
Q1 		$64K Hold
1,000
– – ﹤0.01% 4850
2014
Q4 		$62K Buy
1,000
+500
+100% +$24.7K ﹤0.01% 4956
2014
Q3 		$19K Buy
+500
New +$17.7K ﹤0.01% 5303

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada's IONS Position: Q1 2026 in Review

Royal Bank of Canada increased its Ionis Pharmaceuticals (IONS) stake by 240% in Q1 2026, buying an estimated $212M and bringing the position to 3,801,815 shares worth $285M. The position accounts for 0.05% of the portfolio, ranked #328.

Royal Bank of Canada first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Royal Bank of Canada held 3,801,815 shares of Ionis Pharmaceuticals worth $285M as of Q1 2026.
  • Royal Bank of Canada bought 2,683,018 Ionis Pharmaceuticals shares in Q1 2026, an estimated $212M.
  • Ionis Pharmaceuticals made up 0.05% of Royal Bank of Canada's portfolio in Q1 2026, its #328 holding.
  • Royal Bank of Canada first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.